Citation Impact
1 by Nobel laureates 1 from Science/Nature 64 standout
Citing Papers
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
2022 Standout
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
2022 Standout
Works of HJ Burstein being referenced
SABRE-B: a randomized phase II trial evaluating the safety and efficacy of combining sunitinib (S) with paclitaxel (P) + bevacizumab (B) as first-line treatment for HER2-negative metastatic breast cancer (MBC): final results.
2009
Phase II study of SU11248, a multitargeted receptor tyrosine kinase inhibitor (TKI), in patients (pts) with previously treated metastatic breast cancer (MBC)
2005
Author Peers
| Author | Oncology | PRM | Cancer Research | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| HJ Burstein | 187 | 61 | 84 | 25 | 219 | |
| Daniela A. Barancelli | 2 | 11 | 342 | |||
| Yapai Song | 3 | 5 | 11 | 365 | ||
| Hossein Fazeli | 6 | 7 | 1 | 31 | 344 | |
| Louis Bordenave | 3 | 1 | 1 | 15 | 985 | |
| Jingmei Lin | 45 | 47 | 116 | 6 | 644 |
All Works
Loading papers...